Summary

14.81 0.04(0.27%)09/27/2024
Park Hotels & Resorts Inc (PK)

Key Facts


1 Day1 Week1 Month3 Months6 Months1 Year5 YearsAll Time
0.30-5.10-0.30-0.47-16.0722.60-35.80-26.81


Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1


Trading Data
Close14.81
Open15.01
High15.11
Low14.69
Volume2,660,960
Change0.05
Change %0.30
Avg Volume (20 Days)2,573,540
Volume/Avg Volume (20 Days) Ratio1.03
52 Week Range11.06 - 18.05
Price vs 52 Week High-17.95%
Price vs 52 Week Low33.91%
Range-1.33
Gap Up/Down0.13
Fundamentals
Market Capitalization (Mln)3,086
EBIDTA42,000,000
PE Ratio0.0000
PEG Ratio1.1411
WallStreet Target Price23.14
Book Value19.0930
Earnings Per Share-2.5880
EPS Estimate Current Quarter-0.3100
EPS Estimate Next Quarter-0.2300
EPS Estimate Current Year-1.9500
EPS Estimate Next Year0.0200
Diluted EPS (TTM)-2.5880
Revenues
Profit Marging-0.6018
Operating Marging (TTM)-0.3360
Return on asset (TTM)-0.0206
Return on equity (TTM)-0.1271
Revenue TTM1,012,000,000
Revenue per share TTM4.2880
Quarterly Revenue Growth (YOY)3.6480
Quarterly Earnings Growth (YOY)-0.9230
Gross Profit (TTM)-168,000,000
Dividends
Dividend Share0.0000
Dividend Yield
Valuations
Trailing PE0.0000
Forward PE59.1716
Price Sales (TTM)0.0000
Price Book (MRQ)0.9616
Revenue Enterprise Value 8.2732
EBITDA Enterprise Value7.5052
Shares
Shares Outstanding236,479,008
Shares Float233,854,260
Shares Short0
Shares Short (Prior Month)0
Shares Ratio0.00
Short Outstanding (%)0.00
Short Float (%)0.00
Insider (%)1.08
Institutions (%)90.49


09/26 07:02 EST - globenewswire.com
Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
-- Single patient in 2mg cohort with stage 3 colon cancer who received 4 prior lines of therapy achieves prolonged stable disease and remains on drug into 6th dosing cycle -- -- No treatment-related adverse events (TRAEs) or dose-limiting toxicities (DLTs) observed to date, including no rash or gastrointestinal (GI) AEs -- -- Systemic exposure at steady-state enables constant target inhibition while avoiding peak plasma toxicities -- -- Half-life of approximately 70 hours supports once-daily or less frequent oral dosing -- -- Distinctive MEK inhibitor profile for the treatment of both NF1-related plexiform and cutaneous neurofibromas, cancer, and other opportunities -- MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other cancer indications, today announced safety, tolerability, pharmacokinetic (PK) and preliminary efficacy data from the first 2 cohorts of patients (n=6) in its Phase 1 clinical trial of PAS-004, being conducted at four clinical sites in the United States.
09/22 09:00 EST - seekingalpha.com
Fed Goes Big
U.S. equity and bond markets exhibited a surprisingly muted response to the Federal Reserve's decision to cut interest rates by 50 basis points, a distinctly dovish pivot following its aggressive tightening cycle. Longer-term benchmark rates actually climbed modestly after the decision in a "curve steepening" trade, reflecting concern that the Fed's dovish tack could revive some inflationary pressures. Led by "pro-cyclical" market segments, the S&P 500 posted gains of 1.1% this week, breaching fresh record highs on Thursday before paring post-Fed gains late in the week.
09/18 08:00 EST - seekingalpha.com
Buried Treasures: 11 Dramatically Undervalued REITs
REIT yields are becoming more competitive, especially with the likelihood of interest rate cuts and low inflation on the horizon. This article identifies 35 equity REITs yielding 4.75% or better and at least 20% undervalued, narrowing down to 11 based on dividend safety, balance sheet quality, and growth projections. Avoid high-yield "sucker" stocks and companies with declining revenues or weak balance sheets to minimize risk and ensure stable returns.
09/16 16:15 EST - globenewswire.com
Park Hotels & Resorts Announces Third Quarter 2024 Earnings Conference Call on October 30, 2024
TYSONS, Va., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Park Hotels & Resorts Inc. (“Park”) (NYSE: PK) today announced that it plans to report financial results for the third quarter 2024 after the stock market closes on Tuesday, October 29, 2024. Park will hold a conference call on Wednesday, October 30, 2024, at 11:00 a.m. Eastern Time (ET) to discuss its earnings results, current operational environment and business outlook.
09/10 10:13 EST - forbes.com
This Stock Has A 7.10% Yield And Sells For Less Than Book
Park Hotels & Resorts has been named as a Top 10 Real Estate Investment Trust (REIT), according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among REITs, PK shares displayed both attractive valuation metrics and strong profitability metrics.
08/26 16:55 EST - globenewswire.com
Park Hotels & Resorts Provides Update on Hurricane Hone
TYSONS, Va., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Park Hotels & Resorts Inc. (NYSE) ("Park") announced today that its two Hawaii hotels—the 2,860-room Hilton Hawaiian Village in Honolulu and the 647-room Hilton Waikoloa Village on the Big Island—sustained no material damage from Hurricane Hone, a Category 1 hurricane that impacted the Hawaiian Islands on Sunday. Both hotels maintained power and uninterrupted services, and continue to welcome guests with all customary services and amenities available.
08/26 09:40 EST - accesswire.com
Camber Energy Reports Q-2 2024 Revenue of $9.92 Million
Historical Q-2 Revenue Comparison Highlights Significant Growth HOUSTON, TX / ACCESSWIRE / August 26, 2024 / Camber Energy, Inc. (OTC:PK:CEIN) ("Camber" or the "Company") filed on August 26, 2024 its quarterly report on Form 10-Q for the quarter ended 6/30/2024 and is pleased to share a comparison of revenues reported in Q-2 2024 versus revenues reported by the Company in Q-2 for the preceding three years. Q-2 Historical Reported Revenue Comparison: Revenues for Q-2 2024 were derived primarily from the Company's power solutions' business, including from the design, sale and/or service of power generation units and systems.
08/22 09:11 EST - seekingalpha.com
69 All Star And Graham Value Stocks; 49 Fit To Buy In August
Large Cap Value ranking by YCharts focuses on intrinsic firm value of large cap stocks. The Ben Graham Formula strategy selects stable stocks based on earnings, dividends, and valuation based on Graham's book “The Intelligent Investor”. 49 out of 69 All-Star Value Dividend stocks offer annual dividends (from $1K invested) exceeding their price per share. 5 of the 69 showed yields exceeding 25% and were disqualified as unsustainable.
08/05 12:48 EST - seekingalpha.com
Park Hotels: A Good REIT Story Facing Costs, Labor Headwinds
Park Hotels is at an early stage of recovery, not yet reflected in its price.
07/31 20:30 EST - zacks.com
Compared to Estimates, Park Hotels & Resorts (PK) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Park Hotels & Resorts (PK) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
07/31 19:05 EST - zacks.com
Park Hotels & Resorts (PK) Tops Q2 FFO Estimates
Park Hotels & Resorts (PK) came out with quarterly funds from operations (FFO) of $0.65 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to FFO of $0.60 per share a year ago.
07/31 16:15 EST - globenewswire.com
Park Hotels & Resorts Inc. Reports Second Quarter 2024 Results
TYSONS, Va., July 31, 2024 (GLOBE NEWSWIRE) -- Park Hotels & Resorts Inc. (“Park” or the “Company”) (NYSE: PK) today announced results for the second quarter ended June 30, 2024 and provided an operational update.
07/22 09:05 EST - zacks.com
5 Stocks With Attractive Price-to-Book Ratio Worth a Look
The P/B ratio helps to identify low-priced stocks with high growth prospects General Motors Company (GM), Park Hotels & Resorts (PK), StoneCo (STNE), EnerSys (ENS) and PayPal (PYPL) are some such stocks.
07/20 08:00 EST - marketwatch.com
20 value stocks with high dividend yields and expected room to raise payouts
Last week's action in the stock market might have signaled a long-awaited shift away from a focus on Big Tech in the stock market to overlooked pockets of value.
07/17 09:05 EST - zacks.com
Best Value Stocks to Buy for July 17th
INN, PK and KBH made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 17, 2024.
07/17 08:45 EST - zacks.com
Best Income Stocks to Buy for July 17th
PK, INN and JHG made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 17, 2024.
07/15 10:41 EST - zacks.com
Are Investors Undervaluing Park Hotels & Resorts (PK) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
07/11 09:05 EST - zacks.com
Tap These 5 Bargain Stocks With Impressive EV-to-EBITDA Ratio
We have screened bargain stocks PK, KELYA, DNOW, KBH and AIR based on the EV-to-EBITDA ratio, which offers a clearer picture of valuation and earnings potential.
07/11 04:55 EST - zacks.com
Best Income Stocks to Buy for July 11th
KRO, HMC, and PK made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 11, 2024.
07/11 04:40 EST - zacks.com
Best Value Stocks to Buy for July 11th
JXN, PK, and RGA made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 11, 2024.